drugset / Trial / NCT03649009
Thiamine As An Adjuvant Therapy For Hyperlactatemia In Septic Shock Patients
RandomizedParallel-groupSingle-blindPrevention
Summary
The study aimed to assess the effectiveness of intravenous thiamine as compared with placebo in reducing the lactate level in septic shock patients.
Timeline
- Start
- 2018-01-01
- Primary completion
- 2018-12-01
- Completion
- 2019-03-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Thiamine | Other / unclassified | 200 mg | Intravenous |
| Comparator | Hydrocortisone | Other / unclassified | 200 mg | Intravenous |